LATEST WEBINARS
Webinar live date: Tuesday 14 May 201914:00 [BST] 15:00 [CEST] 09:00 [EDT] 06:00 [PDT]. Arno Kromminga and Lydia Michaut will discuss the strategies and challenges of immunogenicity assessment for gene therapy compounds.
In this free on demand panel discussion, our experts provide insights into their own research with cellular and gene therapies including the challenges they have had to overcome, key trends they have seen and their future outlook of the development of this field.
The speakers from our January panel discussion on immunogenicity answer further questions from the live event
We present a rare opportunity to see experts from across the pharmaceutical and CRO industries sharing perspectives on FDA guidance, transitioning skills and future hopes for the bio lab.
Webinar available to view on demand. In this case study, Alturas Analytics (ID, USA) presents the techniques they use in their labs for optimal analysis of large molecules from biological matrices.
Thank you everyone who attended our live webinar ‘Clinical relevance of (unwanted drug induced) immune responses’. Here are some responses to the questions posed during the live event that we did not have time to answer.
Webinar available to view on demand. In this free panel discussion, our experts will provide insights into their own research with immunogenicity including the challenges they have had to overcome, key trends they have seen and their future outlook of the development of this field.
Webinar available to view on demand. Exploring the challenges a lack of industry standardization presents for CRO project managers and scientists as well as biopharma and biotech companies.
Webinar available to view on demand. This webinar will give an overview of immunogenicity assay development, explore the impact of anti-drug antibodies on bioanalysis and review relevant case studies discussing in-study cut-point and tolerance.
Webinar available to view on demand. Learn how a standardized approach for the bioanalysis of biotherapeutics by hybrid LC–MS is applied in a contract research environment, whilst also considering compliance with regulatory requirements.
Latest News
Researchers have developed a novel technology to test for viral infections by detecting small amounts of antibodies in the blood.
A prototype wearable device has been developed to continuously collect live cancer cells directly from a patient’s blood, presenting an alternative to biopsies.
Take a look at our overview of the top events in the world of bioanalysis for April, May and June 2019.
Latest Features
In this conference report we discuss our highlights from the 13th Workshop on Recent Issues in Bioanalysis (WRIB; New Orleans, USA; 1–4 April).
As part of our mini-Spotlight on cell and gene therapies, we carried out a survey to gain an insight into the trends, challenges and developments associated with these fields – find out the results in this informative infographic.
Find out more about the challenges associated with gene therapy and what the future may hold for the field in this interview with Hugh Davis (Frontage Laboratories; PA, USA).
Drug Discovery and Development
Bioanalytical laboratory considerations for immuno-oncology drug development
Spotlight survey on proteomics
Chip off the old block: novel lab-on-a-chip techniques for R&D
Ligand-binding
Biotherapeutic characterization and quantification: an interview with Pegah Jalili
Hybrid assays: the next big thing?
Evolution of fit-for-purpose biomarker validations: an LBA perspective
Mass Spectrometry
An author’s perspective: Laura Rowe on analyzing protein glycosylation using UHPLC
Sample preparation, extraction & collection
In the Zone: alternative matrices
Noninvasive method potentially as effective at measuring blood glucose as finger prick test
Nanopore system offers real-time single molecule analysis of complex biological samples